Bonus: The Path with Becky Quick: A Father’s Rare Determination 7/2/26
John Crowley does not stop at bad news. His two young children, Megan and Patrick, were babies when they were diagnosed with Pompe disease, a rare and fatal form of muscular dystrophy. Crowley changed his entire life in a race against the clock to find a treatment for his kids and reinvented his career at the same time. It was a breakthrough that inspired a Hollywood film, he tells Becky Quick for CNBC Cures. Since then, Crowley has built two biotech companies focused on rare diseases that were later acquired by larger pharmaceuticals and today leads the industry lobbying group, BIO. Check out the video playlist of the first season of The Path: https://www.youtube.com/playlist?list=PLVbP054jv0Ko-hAZBSDwZaejelC-FMjc_ Join us in advancing awareness and understanding of rare diseases. Visit CNBC.com/Cures to access more clips, resources, or to sign up for our weekly newsletter. Learn more about rare disease – and what to do in a diagnosis – at the National Organization for Rare Disorders: https://rarediseases.org/ Follow Becky Quick on X: @BeckyQuick Please share your thoughts or rare disease story in the comments, and join us on The Path.
You May Also Like

How to Money
iHeartPodcasts

The Chad & Cheese Podcast
Evergreen Podcasts

Your Money Minute
CNBC

🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen

Dagen med Di
Dagens industri

Brushwood Media Network
Brushwood Media Network

Contas-Poupança
Pedro Andersson

Happy Work - Bien-être au travail et management bienveillant
Gaël Chatelain-Berry

Datasets
Visionary

Alles auf Aktien – Die täglichen Finanzen-News
WELT
Community discussion